Literature DB >> 19085939

Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.

Richard van Wijk1, Eric G Huizinga, Annet C W van Wesel, Brigitte A van Oirschot, Michael A Hadders, Wouter W van Solinge.   

Abstract

Pyruvate kinase (PK) deficiency is a rare disease but an important cause of hereditary nonspherocytic hemolytic anemia. The disease is caused by mutations in the PKLR gene and shows a marked variability in clinical expression. We report on the molecular characterization of 38 PK-deficient patients from 35 unrelated families. Twenty-nine different PKLR mutations were detected, of which 15 are reported here for the first time. Two novel deletions are reported: c.142_159del18 is the largest in-frame deletion described thus far and predicts the loss of six consecutive amino acids (p.Thr48_Thr53del) in the N-terminal domain of red blood cell PK. The other deletion removes nearly 1.5 kb of genomic DNA sequence (c.1618+37_2064del1477) and is one of a few large deletional mutants in PKLR. In addition, 13 novel point mutations were identified: one nonsense mutant, p.Arg488X, and 12 missense mutations, predicting the substitution of a single amino acid: p.Arg40Trp, p.Leu73Pro, p.Ile90Asn, p.Gly111Arg, p.Ala154Thr, p.Arg163Leu, p.Gly165Val, p.Leu272Val, p.Ile310Asn, p.Val320Leu, p.Gly358Glu, and p.Leu374Pro. We used the three-dimensional (3D) structure of recombinant human tetrameric PK to evaluate the protein structural context of the affected residues. In addition, in selected patients red blood cell PK antigen levels were measured by enzyme-linked immunosorbent assay (ELISA). Collectively, the results provided us with a rationale for the observed enzyme deficiency and contribute to both a better understanding of the genotype-to-phenotype correlation in PK deficiency as well as the enzyme's structure and function. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19085939     DOI: 10.1002/humu.20915

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  The lid domain is important, but not essential, for catalysis of Escherichia coli pyruvate kinase.

Authors:  Elena Sugrue; David Coombes; David Wood; Tong Zhu; Katherine A Donovan; Renwick C J Dobson
Journal:  Eur Biophys J       Date:  2020-09-25       Impact factor: 1.733

2.  Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications.

Authors:  Gholson J Lyon; Tao Jiang; Richard Van Wijk; Wei Wang; Paul Mark Bodily; Jinchuan Xing; Lifeng Tian; Reid J Robison; Mark Clement; Yang Lin; Peng Zhang; Ying Liu; Barry Moore; Joseph T Glessner; Josephine Elia; Fred Reimherr; Wouter W van Solinge; Mark Yandell; Hakon Hakonarson; Jun Wang; William Evan Johnson; Zhi Wei; Kai Wang
Journal:  Discov Med       Date:  2011-07       Impact factor: 2.970

3.  A Proposed Concept for Defective Mitophagy Leading to Late Stage Ineffective Erythropoiesis in Pyruvate Kinase Deficiency.

Authors:  Annelies Johanna van Vuren; Eduard Johannes van Beers; Richard van Wijk
Journal:  Front Physiol       Date:  2021-01-20       Impact factor: 4.566

4.  Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population.

Authors:  Rebekah van Bruggen; Christian Gualtieri; Alexandra Iliescu; Chalisa Louicharoen Cheepsunthorn; Punchalee Mungkalasut; Jean-François Trape; David Modiano; Bienvenu Sodiomon Sirima; Pratap Singhasivanon; Mark Lathrop; Anavaj Sakuntabhai; Jean-François Bureau; Philippe Gros
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

5.  Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.

Authors:  Dominique B Figueroa; Joseph Tillotson; Maoji Li; Estelle Piwowar-Manning; Craig W Hendrix; Timothy H Holtz; Kevin Bokoch; Linda-Gail Bekker; Frits van Griensven; Sharon Mannheimer; James P Hughes; Robert M Grant; Namandjé N Bumpus
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

Review 6.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.